Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm

A legfontosabb adatok

Hol
Wesley Chapel (Egyesült Államok)A helyszín megnézése

Helyszínek itt: Egyesült Államok

  • Orlando Health Wiregrass Ranch HospitalWesley Chapel, Egyesült ÁllamokContact: TIna HendersonRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Konstantinos Arnaoutakis, MD
Azonosító
NCT05195905
A regiszteradat frissítve
2026. október 16.
Eredeti leírás
The primary objective is to evaluate the safety and effectiveness of surgeon modified endografts for the treatment of pararenal and thoracoabdominal aortic pathology in patients who are not candidate for traditional open repair due to comorbid issues and their anatomy is not amenable to commercially available endografts.A teljes eredeti leírásKevesebb

Evaluation of Spinal Cord Ischemia and Mortality and Morbidity After Endovascular Repair of Pararenal and Thoracoabdominal Aortic Aneurysm Using Surgeon-Modified Endografts

The primary objective is to evaluate the safety and effectiveness of surgeon modified endografts for the treatment of pararenal and thoracoabdominal aortic pathology in patients who are not candidate for traditional open repair due to comorbid issues and their anatomy is not amenable to commercially available endografts.

Bevonási feltételek: Provision of signed and dated informed consent form; Male or female, aged ≥18 years; Expected survival beyond 1 year following successful aneurysm repair; Anatomy that would require coverage of the celiac artery, superior mesenteric artery (SMA), and/or renal arteries if conventional, FDA-approved endograft were implanted to obtain adequate sealing zone length; Aneurysm of the thoracoabdominal or pararenal aorta with or without chronic dissection; Adequate proximal zone of fixation; Adequate distal zone of fixation; No more than 5 non-aneurysmal visceral (celiac, SMA, or renal) arteries with diameters between 4-12mm; Adequate arterial access for delivery system; use of iliac conduit is permitted as necessary.

Kizáró feltételek: Pregnancy or lactation (confirmed per standard of care surgical practice); Major, unrelated surgical procedure planned ≤30 days from endovascular repair; Patient is ≤30 days beyond primary endpoint for another investigative clinical drug/device trial; Unstable angina; Stroke or MI within 3 months of planned treatment date; Active systemic infection and/or mycotic aneurysm; Uncorrectable coagulopathy or other bleeding diathesis; Known allergy to device material or contrast material that cannot be adequately pre-medicated; Baseline eGFR < 30ml/min, unless currently on or to be initiating dialysis; Moderate-to-severe aortic neck calcification, thrombus, or tortuosity; Severe iliac stenosis, calcification, or tortuosity with no ability to perform a conduit; Proximal landing within zone 0 or 1; Inability to maintain at least one patent hypogastric artery; Freely ruptured aneurysm with hemodynamic instability; Non-ambulatory status; Severe CHF; Body habitus that would preclude adequate fluoroscopic visualization of aorta; Social or psychological issues that would interfere with ability to comply with all study procedures for the duration of the study; Can be treated in accordance with the instructions for use with a legally marketed endovascular device, including a manufacturer-fabricated custom device; Can enroll in a manufacturer-sponsored clinical study at our institution or is willing and eligible to participate in a study with a manufacturer-made device at another institution.

ClinicalTrials.gov NCT05195905